A federal court ruled in favor of Latham & Watkins and against Sidley Austin in a dispute over the U.S. Food and Drug Administration's approval of a powerful sleep disorder drug.

U.S. District Judge Amit P. Mehta for the District of Columbia upheld the FDA's approval of the narcolepsy drug Lumryz and denied a Sidley motion for summary judgment.